GlassScriptPhysician profile
Adam Nasreddine
NPI 1710476338
$12,674.80
in general payments reported to CMS, 2019-2025
10 companies · $5,323 in 2025
The $5,323 reported for 2025 was more than what 87% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,402 · 2023: $519 · 2024: $5,432 · 2025: $5,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,667 · Travel and Lodging: $2,158 · Food and Beverage: $2,001 · Education: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,666.66 |
| Travel and Lodging | $2,158.11 |
| Food and Beverage | $2,000.56 |
| Education | $447.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,721.02 | 2024-2025 | Double Endobutton, Healicoil, The Pink Hip Kit - Smith & Nephew Table |
| Orthofix Medical, INC. | $1,401.51 | 2021 | |
| Arthrex, INC. | $1,251.34 | 2025 | |
| Stryker Corporation | $577.98 | 2023-2025 | Procinch, 7 X 23mm Citrelock Implant, Ortholoc 3di Crosscheck |
| Elite Orthopedics, LLC | $335.03 | 2025 | |
| Medtronic, INC. | $173.72 | 2023 | |
| Kairos Surgical INC | $77.26 | 2024-2025 | |
| Axogen | $76.18 | 2023 | Avance Nerve Graft |
| Medical Device Business Services, INC. | $35.76 | 2023 | |
| Vericel Corporation | $25.00 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Nasreddine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.